Skip to content
naulon
Get started

No retraction, correction or concern found when last checked on Oct 23, 2026.

Vitamin D Deficiency and Oral Health: A Comprehensive Review

João Botelho, Vanessa Machado, Luís Proença and 2 more

Nutrients · 2020 · Review · CC BY

doi:10.3390/nu12051471

Abstract

Vitamin D (VD) levels have been gaining growing attention in Oral Health. During growth and adulthood, VD deficiency (VDD) is associated with a wide variety of oral health disorders, and impaired VD synthesis may expedite some of these conditions. In children, severe VDD can induce defective tooth mineralization, resulting in dentin and enamel defects. As a consequence, these defects may increase the risk of the onset and progression of dental caries. Further, VDD has been associated with higher prevalence of periodontitis and gingival inflammation, and several recent preclinical and clinical studies have unveiled potential pathways through which Vitamin D may interact with the periodontium. VDD correction through supplementation may contribute to a successful treatment of periodontitis; however, alveolar bone regeneration procedures performed in baseline VDD patients seem more prone to failure. Vitamin D may also be linked with some oral pathology entities such as certain oral cancers and events of osteonecrosis of the jaw. This review aims to provide comprehensive evidence of how VD levels should be considered to promote good oral health, and to summarize how VDD may hamper oral development and its role in certain oral conditions.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 23, 2026. Paragraph numbers are ours, so an answer can point at one.

1. Introduction

Vitamin D is a steroid hormone obtained mainly from exposure to sunlight, but also from diet and dietary supplements. Foods naturally containing vitamin D are rare, and it can be found in oily fish (such as salmon, mackerel, and herring) and oils from fish (e.g., cod liver oil). Vitamin D is a generic name comprising Vitamin D2 and D3. While Vitamin D2 is manufactured through ultraviolet irradiation of ergosterol from yeast, Vitamin D3 results from ultraviolet irradiation of 7-dehydrocholesterol from lanolin (Figure 1) exhibiting the biological activity of cholecalciferol (vitamin D3), and it is synthesized in the human skin. Measurement of serum 25-hydroxyvitamin D (25[OH]D) is a widely accepted biomarker analysis for vitamin D status.

Vitamin D acts primordially as a hormone, and its endocrine activity promotes serum calcium and phosphate homeostasis through intestinal absorption regulation (Figure 1). Vitamin D also acts like an autocrine and paracrine agent, regulating cell differentiation, cell maturation and innate immune system. In detail, the cellular actions of Vitamin D are mediated through the Vitamin D receptor (VDR), which is a receptor molecule that binds to the active form of Vitamin D (Figure 2). As such, Vitamin D actions depend on the regulation of VDR for its genomic effects and on a membrane associated proteins to nongenomic effects (such as signaling pathways) (Figure 2). This vast action is due to the fact that this vitamin modulates the expression of a considerable number of genes, and it is estimated to do so for 5–10% of the entire genome.

Public awareness of vitamin D has increased exponentially due to a worldwide prevalence of vitamin D deficiency (VDD). This prevalence is worrisome and is of the utmost importance for general health, with special focus on children, pregnancy, some forms of cancer and infection prevention.

In general, the major cause of VDD is the lack of exposure to sunlight with adequate ultraviolet B rays (exogenous factor). VDD can also arise from a nutritional deficit due to inadequate intakes of vitamin D, or hereditary disorders from absorption and metabolic conversion. Additionally, drug related VDD is also possible due to iatrogenic increased clearance (for instance, with phenytoin, carbamazepine and oxcarbazepine regimens).

The role of nutrition in oral diseases has gained popularity and recent investigations have uncovered increasingly relevant relationships between nutritional deficits and oral pathologies. Concerning oral diseases, caries and periodontal diseases are complex multifactorial diseases and remain the two most prevalent diseases worldwide. Both caries and periodontal disease are associated with VDD and its pathophysiologic processes. The mechanisms by which vitamin D impacts oral health are not just based on bone metabolism. Nowadays, research has unveiled that VDD compromises odontogenesis, resulting in a hypomineralized dentition susceptible to fracture and caries lesions. VDD was also linked to worse periodontal health and might be involved in the immune mechanism towards periodontal infection. Furthermore, VDD in association with periodontitis has been recently linked to potential systemic repercussions during pregnancy, throughout orthodontic treatment, in post-menopausal women or in some oral pathologies.

The latest breakthroughs led us to elaborate a review aiming to comprehensively summarize the available evidence of the effect of vitamin D on oral health and its major complications. Furthermore, we discuss the impact of recent studies where VDD correction was implemented through supplementation which might underpin future clinical guidelines.

2.1. Vitamin D Deficiency in Tooth Mineralization and Caries

Teeth are mineralized organs, surrounded by alveolar bone, and formed by three distinctive hard tissues: enamel, dentin, and cementum. The tooth mineralization process occurs parallel to skeletal mineralization, yet if mineral metabolism is disturbed then failures will occur similarly to those that occur in bone tissue. Vitamin D plays a key role in bone and tooth mineralization, and when levels are unregulated it can lead to the “rachitic tooth”, which is a defective and hypomineralized organ highly susceptible to fracture and decay.

The mechanisms by which VDD affects tooth mineralization are well debated elsewhere. The main biological basis relies on the fact that severe VDD (<10 ng/mL) causes hypocalcemia and hypophosphatemia with secondary hyperparathyroidism (driven by hypocalcemia). This hyperparathyroidism promotes intestinal absorption of calcium (Ca2+), and renal production of 1 α,25-dihydroxyvitamin D (1,25[OH]2D), increasing bone turnover leading to elevated serum levels of Ca2+ and low serum levels of inorganic phosphate (Pi). The initial hypophosphatemia is then severely worsened. Ultimately, the loss of vitamin D signaling pathways in tooth cells with low concentrations of Ca2+ and phosphate ions inhibit proper mineralization of teeth and mineralization defects occur.

Apart from its mineralization homeostasis role, circulating vitamin D can initiate a signaling pathway through vitamin D receptors (VDR). VDR is a ligand-activated transcription factor that controls gene expression through vitamin D elements (VDRE). For instance, some of these responsive genes affect bone, mineral metabolism, immune response, cell life cycle and migration, skeletal muscle, detoxification, and energy metabolism. Vitamin D upregulates VDR which, in turn, can induce structural gene products, including calcium-binding proteins and various extracellular matrix proteins (e.g., enamels, amelogenins, dentin sialoglycoproteins, and dentin phosphoproteins), resulting in the formation of dentin and enamel.

Beyond the typical VDD causes, nutritional deficiency or reduction of sunlight exposure, there are genetic deficiencies originating from mutations encoding elements of the vitamin D metabolic machinery. The main causes of VDD, second to genetic mutations, are abnormal enzyme secretion (i.e., vitamin D-dependent rickets type 1, VDDR-I) and anomalous VDR function or signaling (vitamin D-dependent rickets type 2, VDDR-IIa; hereditary defects in the vitamin D receptor-effector system, HDVDR). These genetic conditions cause defective mineralized tissues, despite normal vitamin D consumption or sunlight exposure and, ultimately, will increase the risk of mineralized tooth tissue hypoplasia (i.e., amelogenesis imperfecta, dentinogenesis imperfecta, enamel hypoplasia) or higher risk of caries.

Remarkably, deciduous dentition can be influenced by maternal 25(OH)D levels, despite the influence of inherited defects of the fetus. Fetal serum-circulating levels of vitamin D follow the maternal concentration and can be used as a standard surrogate marker to the fetus. Therefore, if maternal 25(OH)D levels turn unbalanced, this may have direct repercussions on the baby’s health and, in particular, on tooth development. The pattern of mineralization defect depends on the specific week of gestation when maternal VDD occurred. For example, approximately at the 13th week from conception, the human primary maxillary central incisor begins its calcification, and if there is a VDD status, there could be a hypoplasia/mineralization defect on the incisal third of the crown. Nowadays, it is known that maternal VDD at 12–16, 20–32 and 36–40 weeks results in defects at the incisal third, middle third and cervical third, respectively. In a randomized clinical trial (RCT), vitamin D supplementation during pregnancy revealed that pregnant women with < 15 ng/mL of vitamin D had a 14% higher risk of deciduous dentition. In contrast, high-dose vitamin D supplementation during pregnancy was associated with an approximately 50% reduced odds of enamel defects. In another RCT, high-dose Vitamin D supplementation during pregnancy was linked to 50% lower risk of enamel defects in the newborn, underlying once more the likely preventive role of Vitamin D for enamel defects.

Furthermore, untreated caries in deciduous and permanent teeth were the most prevalent condition, affecting 9% and 35% of global population, respectively. Moreover, according to WHO, caries is the fourth-most expensive chronic disease to treat. This infectious disease has a complex and multifactorial etiology. Environmental factors, such as cariogenic diet with a high carbohydrate content, cariogenic bacteria, and poor oral hygiene were the most widely studied risk factors. Nevertheless, when exposed to the same environmental risk factors, some patients are more susceptible or resistant to caries than others, so that environmental factors alone are insufficient to explain the prevalence and incidence of caries. Currently the evidence highlights the association of low levels of vitamin D and the high prevalence of caries in both children and adults, although the mechanism remains unclear.

Additionally, vitamin D exerts several roles in the control of the human immune system, and an optimal vitamin D concentration (≥75 nmol/L) is associated with lower odds for dental caries in children. However, the studies’ results are contradictory. A recent systematic review of controlled clinical trials, with data from 2827 children, investigated the impact of vitamin D supplementation on dental caries prevention. The results of this study show that vitamin D supplementation reduced the risk of caries in about 47%, but with low certainty. Another research supports that caries-free children were twice as likely to have optimal vitamin D concentrations (≥75 nmol/L) and those with severe early childhood caries were at nearly three times the odds of having deficient levels (<35 nmol/L). On the one hand, it is important to clarify that serum vitamin D does not change the major structure of teeth since this structure remains constant until some extrinsic factor causes its wear. Notwithstanding, apparently vitamin D prevents caries lesions through immune regulation, promoting microbial eradication with peptide activity as discussed above.

The roles of both UVB and antimicrobial peptides (AMPs) in cariogenic bacteria reduction have been studied. The mechanism through which UVB reduces the risk of dental caries is likely to be through the production of vitamin D and followed by the induction of AMPs, which have antimicrobial properties. AMPs are host defense peptides, mostly cationic and amphiphilic molecules, that are essential elements of the innate immunity against several bacteria, fungi and viruses. Investigations seem to point to a combination of AMPs rather than a specific role of a single AMP, and they have been proposed as potential application for the prevention and treatment of dental caries. Remarkably, Streptococcus mutans, a primary etiological agent of dental caries, may resist host salivary AMPs explaining its virulence in dental caries pathophysiology.

Hence, we can conclude that vitamin D control levels prior to conception may be important to reduce the risk of enamel defects in deciduous teeth and should be controlled throughout pregnancy and after delivery.

2.2. Vitamin D Deficiency and Periodontitis

Periodontitis is a complex polymicrobial disease induced by plaque and with persistent chronic inflammation. Periodontitis is one of the two most prevalent diseases worldwide and its severe stage is the sixth most prevalent, with strong socioeconomic and systemic repercussions. It has great impact on quality of life and is recovered after periodontal therapy. The systemic link between periodontitis and other diseases and conditions has escalated, such as diabetes, ischemic stroke, cardiovascular disease (CVD), rheumatoid arthritis, inflammatory bowel disease, stress, solid-organ transplanted individuals, or preterm birth. Furthermore, the impact of nutrition on periodontal health, and in particular VDD, has been intensively investigated and a recent European consensus stated that an inadequate vitamin D status impacts periodontal health and oral functions.

Several cross-sectional studies have compared the levels of Vitamin D between individuals with periodontitis and without periodontitis; however, the results remain diverse. While most reports show that periodontitis was associated with lower levels of Vitamin D compared to non-periodontitis, another has reported no differences. Further, vitamin D concentrations were associated with higher periodontal destruction, severe periodontitis stages and higher tooth loss. In otherwise healthy patients (CVD and diabetes mellitus), lower levels of Vitamin D were also associated when periodontitis was diagnosed.

Data from the NHANES III study, performed in the USA, showed that individuals with the highest levels of vitamin D experienced 20% less bleeding on probing than those with the lowest levels. Other investigations also demonstrated that lower levels of gingival inflammation are associated with people without periodontitis.

Comprehensively, the inflammatory and immune actions against periodontal pathogens are triggered by the host immune system. As previously mentioned, salivary low levels of vitamin D were associated with higher levels of inflammation biomarkers in periodontitis patients when compared to periodontally healthy patients (namely IL-35, IL-17A and transforming growth factor), supporting the presence of an inflammatory microenvironment. Remarkably, vitamin D supplementation was linked to a decrease of salivary cytokines before nonsurgical periodontal treatment. In addition, a cross-sectional study showed through gingival samples that periodontitis patients exhibited lower levels of VDR and fewer fibroblast cells with higher inflammatory cell infiltration compared with healthy periodontal individuals.

Although not fully understood, Vitamin D has apparent fine-tuning, anti-inflammatory and mineralization effects on the periodontium according to the latest in vitro evidence. A study showed that vitamin D may decrease the number of live porphyromonas gingivalis through active autophagy and might alleviate the inflammatory burden of periodontitis in rodent models: decreasing inflammatory levels (RANKL, TNF-α, IL-1, MMP-9); inhibiting IL-6 overexpression; and suppressing alveolar damage via inhibition of bone loss, apparently through systemic T-helper cells. In cultured human periodontal cells, Vitamin D induced a comparable mineralization effect to vitamin C.

Thus both preclinical and clinical studies support the idea that vitamin D, through its metabolic pathway, might be involved in the pathogenesis of periodontitis, by impacting tooth mineral density and being reversely correlated with disease severity of periodontitis (Figure 3).

From a genetic perspective, the role of VDR variants in periodontitis has been the subject of great consideration. In two recent evidence-based studies, a number of VDR polymorphisms were correlated with higher risk of developing periodontitis. Notwithstanding, the VDR variants’ impact on periodontitis still remains to be consolidated since it depends on the number of studies, and is expected to increase considerably in the future.

On the other hand, the influence of vitamin D supplementation was studied in both nonsurgical and surgical periodontal treatments. Vitamin D and calcium supplementation showed moderate positive effects on periodontal health after nonsurgical periodontal treatment. Further, baseline VDD negatively influenced periodontal surgery outcomes, even when supplementation was used to compensate for low levels (Figure 3). Despite that these studies show vitamin D as a hypothetical hallmark for the success of patients’ treatment, more studies are warranted to infer scientific fallouts and permit definite conclusions.

In addition, a number of reports have explored the association between periodontitis and maternal VDD and found that pregnant women with moderate to severe periodontitis were linked to lower serum levels of vitamin D, compared to women with periodontal health. Importantly, non-surgical periodontal treatment during pregnancy was proved to be successful in reducing adverse pregnancy outcomes; however, concomitant vitamin D supplementation showed mild clinical improvements in birthweight. As such, future studies should assess this relationship in greater detail considering the amount of evidence that Vitamin D impacts periodontal health and maternal health.

2.3. Vitamin D Deficiency and Orthodontics

With the increase in importance of aesthetic requirements, facial micro- and macro-aesthetics and smile have become a priority for adolescents and adults. Consequently, orthodontic treatments have become increasingly prevalent.

Tooth movement relies on the application of predetermined forces that cause mechanical stimuli with two simultaneous processes: (1) bone resorption on the pressure site, through osteoclastic activity; and (2) bone formation on the tension site, by osteoblastic action. These two processes in combination with mechanical, chemical or electrical stimuli, might result in faster teeth movement. Regarding the chemical factors, vitamin D might play a key role in tooth movement during orthodontic treatment and has shown promising results. Albeit animal observational in nature, there is an increasing body of evidence showing that local application of vitamin D results in a faster tooth movement. Notwithstanding, VDD in animal models causes a slower rate of tooth movement, and consequent treatment delay or complications. In this sense, future studies in humans are needed to determine if VDD has a clinically significant effect on tooth movement and if vitamin D supplementation during orthodontic treatment, for instance in hypovitaminosis cases, improves the coupling of formation and resorption in alveolar bone remodeling during orthodontic tooth movement.

2.4. Vitamin D Deficiency and Oral Pathology

Vitamin D might play an important function in the onset and progression of certain oral cancers, though there is still much to research. Remarkably, VDD is more common in patients with oral neoplastic lesions. In a case-control study, VDD was associated with increased risk of squamous cell carcinoma of the esophagus, oral, and pharyngeal cancers, which were more prevalent in heavy smokers and severe alcoholism. Another study has revealed that VDR expression was increased in premalignant lesions and oral cancer, and vitamin D supplementation significantly diminished therapy-related toxicities in late-stage oral cancers, with less morbidity and better quality of life. Therefore, future studies should make efforts to clarify how VDD relates to oral cancer development and its therapeutic efficacy towards anticancer toxicity medications.

The role of VDD in osteonecrosis of the jaw (ONJ) is an increasingly discussed topic; however, Vitamin D status in ONJ individuals remains unestablished. ONJ is characterized by a progressive death of the exposed jawbone in a patient chronically exposed to anti-absorption or anti-angiogenic medications, and no history of mandibular radiotherapy or metastatic disease of the jaw (Patel et al., 2018). Due to its role in bone mineralization, several studies have investigated the levels of Vitamin D in ONJ cases, mainly derived from osteoporosis and cancer patients. The most recent evidence suggests that VDD is not a risk factor for the onset of ONJ events, while other studies underline a potential role. Nonetheless, future studies should focus on the influence of baseline VDD and of Vitamin D supplementation towards ONJ, as well as the establishment of 25(OH)D level standards for patients at high risk of ONJ events.

3. Conclusions

VDD is highly implicated with oral diseases and has been linked with a higher risk of tooth defects, caries, periodontitis and oral treatments failure. The maintenance of appropriate 25(OH)D levels has shown to be associated with better oral development and health throughout life, though the impact of VDD correction through supplementation demands more evidence to allow definitive conclusions and potential clinical guidelines. Nevertheless, 25(OH)D levels should be considered to ensure a balanced oral health, and these levels need to be verified before the treatment of any oral conditions to warrant fruitful treatment outcomes.

References 154

  1. 1.

    Borel P., Caillaud D., Cano N.J. Vitamin D bioavailability: State of the art. Crit. Rev. Food Sci. Nutr. 2015;55:1193-1205.

    Not in our library10.1080/10408398.2012.688897

  2. 2.

    Holick M.F., Chen T.C. Vitamin D deficiency: A worldwide problem with health consequences. Am. J. Clin. Nutr. 2008;87:1080-1086.

    Not in our library10.1093/ajcn/87.4.1080s

  3. 3.

    Turck D., Bresson J.L., Burlingame B., Dean T., Fairweather-Tait S., Heinonen M., Hirsch-Ernst K.I., Mangelsdorf I., McArdle H.J., Naska A., et al. Update of the tolerable upper intake level for vitamin D for infants. EFSA J. 2018;16:1-118.

    Not in our library10.2903/j.efsa.2018.5365

  4. 4.

    Wilson L.R., Tripkovic L., Hart K.H., Lanham-New S.A. Vitamin D deficiency as a public health issue: Using Vitamin D2 or Vitamin D3 in future fortification strategies. Proc. Nutr. Soc. 2017;76:1-8.

    Not in our library10.1017/s0029665117000349

  5. 5.

    Jones G. The discovery and synthesis of the nutritional factor vitamin D. Int. J. Paleopathol. 2018;23:96-99.

    Not in our library10.1016/j.ijpp.2018.01.002

  6. 6.

    Holick M.F. Vitamin D deficiency. N. Engl. J. Med. 2007;357:266-281.

    Not in our library10.1056/nejmra070553

  7. 7.

    Lanham-New S.A., Wilson L.R. Vitamin D—Has the new dawn for dietary recommendations arrived? Nutr. Bull. 2016;41:2-5.

    Not in our library10.1111/nbu.12185

  8. 8.

    Girgis C.M., Clifton-Bligh R.J., Hamrick M.W., Holick M.F., Gunton J.E. The roles of vitamin D in skeletal muscle: Form, function, and metabolism. Endocr. Rev. 2013;34:33-83.

    Not in our library10.1210/er.2012-1012

  9. 9.

    Morris H.A., Anderson P.H. Autocrine and paracrine actions of vitamin d. Clin. Biochem. Rev. 2010;31:129-138.

    Not in our library

  10. 10.

    Bikle D.D. Vitamin D and the immune system: Role in protection against bacterial infection. Curr. Opin. Nephrol. Hypertens. 2008;17:348-352.

    Not in our library10.1097/mnh.0b013e3282ff64a3

  11. 11.

    Bikle D.D. Vitamin D metabolism, mechanism of action, and clinical applications. Chem. Biol. 2014;21:319-329.

    Not in our library10.1016/j.chembiol.2013.12.016

  12. 12.
    Exploring vitamin D metabolism and function in cancer · 2018
    No notice
  13. 13.
    The Vitamin D Receptor and T Cell Function · 2013
    No notice
  14. 14.

    Richard C.L., Farach-Carson M.C., Rohe B., Nemere I., Meckling K.A. Involvement of 1,25D3-MARRS (membrane associated, rapid response steroid-binding), a novel vitamin D receptor, in growth inhibition of breast cancer cells. Exp. Cell Res. 2010;316:695-703.

    Not in our library10.1016/j.yexcr.2009.12.015

  15. 15.

    McKenna M.J., Murray B. Vitamin D Deficiency. 2014.

    Not in our library

  16. 16.

    Hilger J., Friedel A., Herr R., Rausch T., Roos F., Wahl D.A., Pierroz D.D., Weber P., Hoffmann K. A systematic review of vitamin D status in populations worldwide. Br. J. Nutr. 2014;111:23-45.

    Not in our library10.1017/s0007114513001840

  17. 17.

    de Boer I.H. Vitamin D deficiency. Chronic Kidney Disease, Dialysis, and Transplantation. 2010;Volume 357:115-127.

    Not in our library

  18. 18.
    Prevalence of vitamin D deficiency in Africa: a systematic review and meta-analysis · 2020
    Corrected
  19. 19.

    Aguiar M., Andronis L., Pallan M., Högler W., Frew E. The economic case for prevention of population vitamin D deficiency: A modelling study using data from England and Wales. Eur. J. Clin. Nutr. 2019;74:825-833.

    Not in our library10.1038/s41430-019-0486-x

  20. 20.

    Alonso M.A., Mantecón L., Santos F. Vitamin D deficiency in children: A challenging diagnosis! Pediatr. Res. 2019;85:596-601.

    Not in our library10.1038/s41390-019-0289-8

  21. 21.

    White J.H. Vitamin D and human health: More than just bone. Nat. Rev. Endocrinol. 2013;9:623.

    Not in our library10.1038/nrendo.2013.75-c1

  22. 22.

    Fathi N., Ahmadian E., Shahi S., Roshangar L., Khan H., Kouhsoltani M., Maleki Dizaj S., Sharifi S. Role of vitamin D and vitamin D receptor (VDR) in oral cancer. Biomed. Pharmacother. 2019;109:391-401.

    Not in our library10.1016/j.biopha.2018.10.102

  23. 23.

    Gröber U., Kisters K. Influence of drugs on vitamin D and calcium metabolism. Dermatoendocrinology. 2012;4:158-166.

    Not in our library10.4161/derm.20731

  24. 24.

    Chapple I.L.C., Bouchard P., Cagetti M.G., Campus G., Carra M.C., Cocco F., Nibali L., Hujoel P., Laine M.L., Lingstrom P., et al. Interaction of lifestyle, behaviour or systemic diseases with dental caries and periodontal diseases: Consensus report of group 2 of the joint EFP/ORCA workshop on the boundaries between caries and periodontal diseases. J. Clin. Periodontol. 2017;44:S39-S51.

    Not in our library10.1111/jcpe.12685

  25. 25.

    Uwitonze A.M., Murererehe J., Ineza M.C., Harelimana E.I., Nsabimana U., Uwambaye P., Gatarayiha A., Haq A., Razzaque M.S. Effects of vitamin D status on oral health. J. Steroid Biochem. Mol. Biol. 2018;175:190-194.

    Not in our library10.1016/j.jsbmb.2017.01.020

  26. 26.

    Peres M.A., Macpherson L.M.D., Weyant R.J., Daly B., Venturelli R., Mathur M.R., Listl S., Celeste R.K., Guarnizo-Herreño C.C., Kearns C., et al. Oral diseases: A global public health challenge. Lancet. 2019;394:249-260.

    Not in our library10.1016/s0140-6736(19)31146-8

  27. 27.

    Watt R.G., Daly B., Allison P., Macpherson L.M.D., Venturelli R., Listl S., Weyant R.J., Mathur M.R., Guarnizo-Herreño C.C., Celeste R.K., et al. Ending the neglect of global oral health: Time for radical action. Lancet. 2019;394:261-272.

    Not in our library10.1016/s0140-6736(19)31133-x

  28. 28.

    Hujoel P.P. Vitamin D and dental caries in controlled clinical trials: Systematic review and meta-analysis. Nutr. Rev. 2013;71:88-97.

    Not in our library10.1111/j.1753-4887.2012.00544.x

  29. 29.

    Schroth R.J., Levi J.A., Sellers E.A., Friel J., Kliewer E., Moffatt M.E.K. Vitamin D status of children with severe early childhood caries: A case-control study. BMC Pediatr. 2013;13:174.

    Not in our library10.1186/1471-2431-13-174

  30. 30.

    Dietrich T., Joshipura K.J., Dawson-hughes B., Bischoff-ferrari H.A. Association between serum concentrations of 25-hydroxyvitamin D 3 and periodontal disease in the US population 1–3. Am. J. Clin. Nutr. 2004;80:108-113.

    Not in our library10.1093/ajcn/80.1.108

  31. 31.

    Scardina G.A., Messina P. Good oral health and diet. J. Biomed. Biotechnol. 2012;2012:1-8.

    Not in our library10.1155/2012/720692

  32. 32.

    White J.H. Vitamin D metabolism and signaling in the immune system. Rev. Endocr. Metab. Disord. 2012;13:21-29.

    Not in our library10.1007/s11154-011-9195-z

  33. 33.

    Ganesh M.L., Saravana Pandian K. Acceleration of tooth movement during orthodontic treatment-A frontier in orthodontics. J. Pharm. Sci. Res. 2017;9:741-744.

    Not in our library

  34. 34.

    Martínez-Maestre M.A., González-Cejudo C., MacHuca G., Torrejón R., Castelo-Branco C. Periodontitis and osteoporosis: A systematic review. Climacteric. 2010;13:523-529.

    Not in our library10.3109/13697137.2010.500749

  35. 35.

    Foster B.L., Nociti F.H., Somerman M.J. The rachitic tooth. Endocr. Rev. 2014;35:1-34.

    Not in our library10.1210/er.2013-1009

  36. 36.

    D’Ortenzio L., Kahlon B., Peacock T., Salahuddin H., Brickley M. The rachitic tooth: Refining the use of interglobular dentine in diagnosing vitamin D deficiency. Int. J. Paleopathol. 2018;22:101-108.

    Not in our library10.1016/j.ijpp.2018.07.001

  37. 37.

    Allgrove J. Physiology of calcium, phosphate and magnesium. Endocr. Dev. 2009;16:8-31.

    Not in our library10.1159/000223685

  38. 38.

    Bergwitz C., Jüppner H. Regulation of phosphate homeostasis by PTH, Vitamin D, and FGF23. Annu. Rev. Med. 2010;61:91-104.

    Not in our library10.1146/annurev.med.051308.111339

  39. 39.

    Pike J.W., Meyer M.B. The Vitamin D receptor: New paradigms for the regulation of gene expression by 1,25-Dihydroxyvitamin D 3. Rheum. Dis. Clin. N. Am. 2012;38:13-27.

    Not in our library10.1016/j.rdc.2012.03.004

  40. 40.

    Haussler M.R., Jurutka P.W., Mizwicki M., Norman A.W. Vitamin D receptor (VDR)-mediated actions of 1α,25(OH) 2 vitamin D 3: Genomic and non-genomic mechanisms. Best Pract. Res. Clin. Endocrinol. Metab. 2011;25:543-559.

    Not in our library10.1016/j.beem.2011.05.010

  41. 41.

    Pike J.W., Meyer M.B., Bishop K.A. Regulation of target gene expression by the vitamin D receptor—An update on mechanisms. Rev. Endocr. Metab. Disord. 2012;13:45-55.

    Not in our library10.1007/s11154-011-9198-9

  42. 42.

    Rosen C.J., Adams J.S., Bikle D.D., Black D.M., Demay M.B., Manson J.A.E., Murad M.H., Kovacs C.S. The nonskeletal effects of vitamin D: An endocrine society scientific statement. Endocr. Rev. 2012;33:456-492.

    Not in our library10.1210/er.2012-1000

  43. 43.

    Haussler M.R., Haussler C.A., Whitfield G.K., Hsieh J.C., Thompson P.D., Barthel T.K., Bartik L., Egan J.B., Wu Y., Kubicek J.L., et al. The nuclear vitamin D receptor controls the expression of genes encoding factors which feed the “ Fountain of Youth” to mediate healthful aging. J. Steroid Biochem. Mol. Biol. 2010;121:88-97.

    Not in our library10.1016/j.jsbmb.2010.03.019

  44. 44.

    Slavkin H.C., Hu C.C., Sakakura Y., Diekwisch T., Chai Y., Mayo M., Bringas P., Simmer J., Mak G., Sasano Y., et al. Gene expression, signal transduction and tissue-specific biomineralization during mammalian tooth development. Crit. Rev. Eukaryot. Gene Expr. 1992;2:315-329.

    Not in our library

  45. 45.

    Schroth R.J., Lavelle C., Tate R., Bruce S., Billings R.J., Moffatt M.E.K. Prenatal vitamin D and dental caries in infants. Pediatrics. 2014;133:133.

    Not in our library10.1542/peds.2013-2215

  46. 46.

    Singleton R., Day G., Thomas T., Schroth R., Klejka J., Lenaker D., Berner J. Association of maternal Vitamin D deficiency with early childhood caries. J. Dent. Res. 2019;98:549-555.

    Not in our library10.1177/0022034519834518

  47. 47.

    Hollist B.W., Pittard W.B. Evaluation of the total fetomaternal vitamin d relationships at term: Evidence for racial differences. J. Clin. Endocrinol. Metab. 1984;59:652-657.

    Not in our library10.1210/jcem-59-4-652

  48. 48.

    Karras S.N., Fakhoury H., Muscogiuri G., Grant W.B., van den Ouweland J.M., Colao A.M., Kotsa K. Maternal vitamin D levels during pregnancy and neonatal health: Evidence to date and clinical implications. Ther. Adv. Musculoskelet. Dis. 2016;8:124-135.

    Not in our library10.1177/1759720x16656810

  49. 49.

    Nørrisgaard P.E., Haubek D., Kühnisch J., Chawes B.L., Stokholm J., Bønnelykke K., Bisgaard H. Association of high-dose vitamin d supplementation during pregnancy with the risk of enamel defects in offspring: A 6-year follow-up of a randomized clinical trial. JAMA Pediatr. 2019;173:924-930.

    Not in our library10.1001/jamapediatrics.2019.2545

  50. 50.

    Reed S.G., Miller C.S., Wagner C.L., Hollis B.W., Lawson A.B. Toward preventing enamel hypoplasia: Modeling maternal and neonatal biomarkers of human calcium homeostasis. Caries Res. 2020;54:55-67.

    Not in our library10.1159/000502793

  51. 51.

    Reed S.G., Voronca D., Wingate J.S., Murali M., Lawson A.B., Hulsey T.C., Ebeling M.D., Hollis B.W., Wagner C.L. Prenatal vitamin D and enamel hypoplasia in human primary maxillary central incisors: A pilot study. Pediatr. Dent. J. 2017;27:21-28.

    Not in our library10.1016/j.pdj.2016.08.001

  52. 52.

    Tanaka K., Hitsumoto S., Miyake Y., Okubo H., Sasaki S., Miyatake N., Arakawa M. Higher vitamin D intake during pregnancy is associated with reduced risk of dental caries in young Japanese children. Ann. Epidemiol. 2015;25:620-625.

    Not in our library10.1016/j.annepidem.2015.03.020

  53. 53.

    Kassebaum N.J., Bernabé E., Dahiya M., Bhandari B., Murray C.J.L., Marcenes W. Global burden of untreated caries: A systematic review and metaregression. J. Dent. Res. 2015;94:650-658.

    Not in our library10.1177/0022034515573272

  54. 54.

    Petersen P.E. World Health Organization global policy for improvement of oral health—World Health Assembly 2007. Int. Dent. J. 2008;58:342-348.

    Not in our library10.1111/j.1875-595x.2008.tb00185.x

  55. 55.

    Selwitz R.H., Ismail A.I., Pitts N.B. Dental caries. Lancet. 2007;369:51-59.

    Not in our library10.1016/s0140-6736(07)60031-2

  56. 56.

    Conrads G., About I. Pathophysiology of dental caries. Monogr. Oral Sci. 2018;27:1-10.

    Not in our library10.1159/000487826

  57. 57.
    Salivary proteins and microbiota as biomarkers for early childhood caries risk assessment · 2017
    No notice
  58. 58.

    Yildiz G., Ermis R.B., Calapoglu N.S., Celik E.U., Türel G.Y. Gene-environment interactions in the etiology of dental caries. J. Dent. Res. 2016;95:74-79.

    Not in our library10.1177/0022034515605281

  59. 59.

    Rosier B.T., Marsh P.D., Mira A. Resilience of the oral microbiota in health: Mechanisms that prevent dysbiosis. J. Dent. Res. 2018;97:371-380.

    Not in our library10.1177/0022034517742139

  60. 60.

    Jágr M., Eckhardt A., Pataridis S., Foltán R., Myšák J., Mikšík I. Proteomic analysis of human tooth pulp proteomes—Comparison of caries-resistant and caries-susceptible persons. J. Proteom. 2016;145:127-136.

    Not in our library10.1016/j.jprot.2016.04.022

  61. 61.

    Zhou F., Zhou Y., Shi J. The association between serum 25-hydroxyvitamin D levels and dental caries in US adults. Oral Dis. 2020.

    Not in our library10.1111/odi.13360

  62. 62.

    Herzog K., Scott J.M., Hujoel P., Seminario A.L. Association of Vitamin D and dental caries in children Findings from the National Health and Nutrition Examination Survey, 2005–2006. J. Am. Dent. Assoc. 2016;147:413-420.

    Not in our library10.1016/j.adaj.2015.12.013

  63. 63.

    Kim I.J., Lee H.S., Ju H.J., Na J.Y., Oh H.W. A cross-sectional study on the association between vitamin D levels and caries in the permanent dentition of Korean children. BMC Oral Health. 2018;18:43.

    Not in our library10.1186/s12903-018-0505-7

  64. 64.

    Gupta A., Chhonkar A., Arya V. Comparison of Vitamin D level of children with severe early childhood caries and children with no caries. Int. J. Clin. Pediatr. Dent. 2018;11:199-204.

    Not in our library10.5005/jp-journals-10005-1511

  65. 65.

    Deane S., Schroth R.J., Sharma A., Rodd C. Combined deficiencies of 25-hydroxyvitamin D and anemia in preschool children with severe early childhood caries: A case-control study. Paediatr. Child Health. 2018;23:e40-e45.

    Not in our library10.1093/pch/pxx150

  66. 66.

    Guizar J.M., Muñoz N., Amador N., Garcia G. Association of alimentary factors and nutritional status with caries in children of leon, Mexico. Oral Health Prev. Dent. 2016;14:563-569.

    Not in our library10.3290/j.ohpd.a37141

  67. 67.

    Wagner Y., Heinrich-Weltzien R. Evaluation of an interdisciplinary preventive programme for early childhood caries: Findings of a regional German birth cohort study. Clin. Oral Investig. 2016;20:1943-1952.

    Not in our library10.1007/s00784-015-1685-z

  68. 68.

    Schroth R.J., Rabbani R., Loewen G., Moffatt M.E. Vitamin D and dental caries in children. J. Dent. Res. 2016;95:173-179.

    Not in our library10.1177/0022034515616335

  69. 69.

    Wójcik D., Krzewska A., Szalewski L., Pietryka-Michałowska E., Szalewska M., Krzewski S., Pels E., Beń-Skowronek I. Dental caries and Vitamin D 3 in children with growth hormone deficiency. Medicine. 2018;97:e9811.

    Not in our library10.1097/md.0000000000009811

  70. 70.

    Akinkugbe A.A., Moreno O., Brickhouse T.H. Serum cotinine, vitamin D exposure levels and dental caries experience in U.S. adolescents. Community Dent. Oral Epidemiol. 2019;47:185-192.

    Not in our library10.1111/cdoe.12442

  71. 71.

    Gyll J., Ridell K., Öhlund I., Karlsland Åkeson P., Johansson I., Lif Holgerson P. Vitamin D status and dental caries in healthy Swedish children. Nutr. J. 2018;17:11.

    Not in our library10.1186/s12937-018-0318-1

  72. 72.

    Dudding T., Thomas S.J., Duncan K., Lawlor D.A., Timpson N.J. Re-examining the association between Vitamin D and childhood caries. PLoS ONE. 2015;10:e0143769.

    Not in our library10.1371/journal.pone.0143769

  73. 73.

    Kühnisch J., Thiering E., Heinrich-Weltzien R., Hellwig E., Hickel R., Heinrich J. Fluoride/vitamin D tablet supplementation in infants—Effects on dental health after 10 years. Clin. Oral Investig. 2017;21:2283-2290.

    Not in our library10.1007/s00784-016-2021-y

  74. 74.

    Altman H., Steinberg D., Porat Y., Mor A., Fridman D., Friedman M., Bachrach G. In vitro assessment of antimicrobial peptides as potential agents against several oral bacteria. J. Antimicrob. Chemother. 2006;58:198-201.

    Not in our library10.1093/jac/dkl181

  75. 75.

    Grant W.B. A review of the role of solar ultraviolet-B irradiance and vitamin D in reducing risk of dental caries. Dermatoendocrinology. 2011;3:193-198.

    Not in our library10.4161/derm.15841

  76. 76.

    Davidopoulou S., Diza E., Menexes G., Kalfas S. Salivary concentration of the antimicrobial peptide LL-37 in children. Arch. Oral Biol. 2012;57:865-869.

    Not in our library10.1016/j.archoralbio.2012.01.008

  77. 77.

    Phattarataratip E., Olson B., Broffitt B., Qian F., Brogden K.A., Drake D.R., Levy S.M., Banas J.A. Streptococcus mutans strains recovered from caries-active or caries-free individuals differ in sensitivity to host antimicrobial peptides. Mol. Oral Microbiol. 2011;26:187-199.

    Not in our library10.1111/j.2041-1014.2011.00607.x

  78. 78.

    Wong J.H., Ye X.J., Ng T.B. Cathelicidins: Peptides with antimicrobial, immunomodulatory, anti-inflammatory, angiogenic, anticancer and procancer activities. Curr. Protein Pept. Sci. 2013;14:504-514.

    Not in our library10.2174/13892037113149990067

  79. 79.

    Colombo N.H., Ribas L.F.F., Pereira J.A., Kreling P.F., Kressirer C.A., Tanner A.C.R., Duque C. Antimicrobial peptides in saliva of children with severe early childhood caries. Arch. Oral Biol. 2016;69:40-46.

    Not in our library10.1016/j.archoralbio.2016.05.009

  80. 80.

    Goeke J.E., Kist S., Schubert S., Hickel R., Huth K.C., Kollmuss M. Sensitivity of caries pathogens to antimicrobial peptides related to caries risk. Clin. Oral Investig. 2018;22:2519-2525.

    Not in our library10.1007/s00784-018-2348-7

  81. 81.

    Chen Z., Yang G., Lu S., Chen D., Fan S., Xu J., Wu B., He J. Design and antimicrobial activities of LL-37 derivatives inhibiting the formation of Streptococcus mutans biofilm. Chem. Biol. Drug Des. 2019;93:1175-1185.

    Not in our library10.1111/cbdd.13419

  82. 82.

    Darveau R.P. Periodontitis: A polymicrobial disruption of host homeostasis. Nat. Rev. Microbiol. 2010;8:481-490.

    Not in our library10.1038/nrmicro2337

  83. 83.

    Tonetti M.S., Jepsen S., Jin L., Otomo-Corgel J. Impact of the global burden of periodontal diseases on health, nutrition and wellbeing of mankind: A call for global action. J. Clin. Periodontol. 2017;44:456-462.

    Not in our library10.1111/jcpe.12732

  84. 84.

    Machado V., Botelho J., Amaral A., Proença L., Alves R., Rua J., Cavacas M.A., Delgado A.S., Mendes J.J. Prevalence and extent of chronic periodontitis and its risk factors in a Portuguese subpopulation: A retrospective cross-sectional study and analysis of clinical attachment loss. PeerJ. 2018;6:e5258.

    Not in our library10.7717/peerj.5258

  85. 85.

    Botelho J., Machado V., Proença L., Alves R., Cavacas M.A., Amaro L., Mendes J.J. Study of Periodontal Health in Almada-Seixal (SoPHiAS): A cross-sectional study in the Lisbon Metropolitan Area. Sci. Rep. 2019;9.

    Not in our library10.1038/s41598-019-52116-6

  86. 86.

    Buset S.L., Walter C., Friedmann A., Weiger R., Borgnakke W.S., Zitzmann N.U. Are periodontal diseases really silent? A systematic review of their effect on quality of life. J. Clin. Periodontol. 2016;43:333-344.

    Not in our library10.1111/jcpe.12517

  87. 87.

    Botelho J., Machado V., Proença L., Bellini D.H., Chambrone L., Alcoforado G., Mendes J.J. The impact of nonsurgical periodontal treatment on oral health-related quality of life: A systematic review and meta-analysis. Clin. Oral Investig. 2020;24:585-596.

    Not in our library10.1007/s00784-019-03188-1

  88. 88.

    Preshaw P.M., Alba A.L., Herrera D., Jepsen S., Konstantinidis A., Makrilakis K., Taylor R. Periodontitis and diabetes: A two-way relationship Matrix metalloproteinase NHANES National Health and Nutrition Examination Survey. Diabetologia. 2012;55:21-31.

    Not in our library10.1007/s00125-011-2342-y

  89. 89.

    Leira Y., Seoane J., Blanco M., Rodríguez-Yáñez M., Takkouche B., Blanco J., Castillo J. Association between periodontitis and ischemic stroke: A systematic review and meta-analysis. Eur. J. Epidemiol. 2017;32:43-53.

    Not in our library10.1007/s10654-016-0170-6

  90. 90.

    Muñoz Aguilera E., Suvan J., Buti J., Czesnikiewicz-Guzik M., Barbosa Ribeiro A., Orlandi M., Guzik T.J., Hingorani A.D., Nart J., D’Aiuto F., et al. Periodontitis is associated with hypertension: A systematic review and meta-analysis. Cardiovasc. Res. 2020;116:28-39.

    Not in our library10.1093/cvr/cvz201

  91. 91.

    Hussain S.B., Botelho J., Machado V., Zehra S.A., Mendes J.J., Ciurtin C., Orlandi M., Aiuto F.D. Is there a bidirectional association between rheumatoid arthritis and periodontitis? A systematic review and meta-analysis. Semin. Arthritis Rheum. 2020.

    Not in our library10.1016/j.semarthrit.2020.01.009

  92. 92.

    Papageorgiou S.N., Hagner M., Nogueira A.V.B., Franke A., Jäger A., Deschner J. Inflammatory bowel disease and oral health: Systematic review and a meta-analysis. J. Clin. Periodontol. 2017;44:382-393.

    Not in our library10.1111/jcpe.12698

  93. 93.

    Botelho J., Machado V., Mascarenhas P., Rua J., Alves R., Cavacas M.A., Delgado A., João Mendes J. Stress, salivary cortisol and periodontitis: A systematic review and meta-analysis of observational studies. Arch. Oral Biol. 2018;96:58-65.

    Not in our library10.1016/j.archoralbio.2018.08.016

  94. 94.

    Machado V., Botelho J., Lopes J., Patrão M., Alves R., Chambrone L., Alcoforado G., Mendes J.J. Periodontitis impact in interleukin-6 serum levels in solid organ transplanted patients: A systematic review and meta-analysis. Diagnostics. 2020;10:184.

    Not in our library10.3390/diagnostics10040184

  95. 95.

    Manrique-Corredor E.J., Orozco-Beltran D., Lopez-Pineda A., Quesada J.A., Gil-Guillen V.F., Carratala-Munuera C. Maternal periodontitis and preterm birth: Systematic review and meta-analysis. Community Dent. Oral Epidemiol. 2019;47:243-251.

    Not in our library10.1111/cdoe.12450

  96. 96.
    The Role of Nutrition in Periodontal Health: An Update · 2016
    No notice
  97. 97.

    Jagelavičienė E., Vaitkevičienė I., Šilingaitė D., Šinkūnaitė E., Daugėlaitė G. The relationship between vitamin D and periodontal pathology. Medicina. 2018;54:45.

    Not in our library10.3390/medicina54030045

  98. 98.

    Garcia M.N., Hildebolt C.F., Miley D.D., Dixon D.A., Couture R.A., Anderson Spearie C.L., Langenwalter E.M., Shannon W.D., Deych E., Mueller C., et al. One-year effects of Vitamin D and calcium supplementation on chronic periodontitis. J. Periodontol. 2011;82:25-32.

    Not in our library10.1902/jop.2010.100207

  99. 99.

    Grant W.B., Boucher B.J. Are hill’s criteria for causality satisfied for vitamin D and periodontal disease? Dermatoendocrinology. 2010;2:30-36.

    Not in our library10.4161/derm.2.1.12488

  100. 100.

    Stein S.H., Livada R., Tipton D.A. Re-evaluating the role of vitamin D in the periodontium. J. Periodontal Res. 2014;49:545-553.

    Not in our library10.1111/jre.12149

  101. 101.

    Anbarcioglu E., Kirtiloglu T., Öztürk A., Kolbakir F., Acıkgöz G., Colak R. Vitamin D deficiency in patients with aggressive periodontitis. Oral Dis. 2019;25:242-249.

    Not in our library10.1111/odi.12968

  102. 102.

    Agrawal A.A., Kolte A.P., Kolte R.A., Chari S., Gupta M., Pakhmode R. Evaluation and comparison of serum vitamin D and calcium levels in periodontally healthy, chronic gingivitis and chronic periodontitis in patients with and without diabetes mellitus–a cross-sectional study. Acta Odontol. Scand. 2019;77:592-599.

    Not in our library10.1080/00016357.2019.1623910

  103. 103.

    Ebersole J.L., Lambert J., Bush H., Huja P.E., Basu A. Serum nutrient levels and aging effects on periodontitis. Nutrients. 2018;10:1986.

    Not in our library10.3390/nu10121986

  104. 104.

    Isola G., Alibrandi A., Rapisarda E., Matarese G., Williams R.C., Leonardi R. Association of vitamin D in patients with periodontitis: A cross-sectional study. J. Periodontal Res. 2020;1-11.

    Not in our library10.1111/jre.12746

  105. 105.

    Ketharanathan V., Torgersen G.R., Petrovski B.É., Preus H.R. Radiographic alveolar bone level and levels of serum 25-OH-Vitamin D 3 in ethnic Norwegian and Tamil periodontitis patients and their periodontally healthy controls. BMC Oral Health. 2019;19:83.

    Not in our library10.1186/s12903-019-0769-6

  106. 106.

    Costantini E., Sinjari B., Piscopo F., Porreca A., Reale M., Caputi S., Murmura G. Evaluation of salivary cytokines and Vitamin D levels in periodontopathic patients. Int. J. Mol. Sci. 2020;21:2669.

    Not in our library10.3390/ijms21082669

  107. 107.

    Zhan Y., Samietz S., Holtfreter B., Hannemann A., Meisel P., Nauck M., Volzke H., Wallaschofski H., Dietrich T., Kocher T., et al. Prospective study of serum 25-hydroxy vitamin d and tooth loss. J. Dent. Res. 2014;93:639-644.

    Not in our library10.1177/0022034514534985

  108. 108.

    Millen A.E., Hovey K.M., LaMonte M.J., Swanson M., Andrews C.A., Kluczynski M.A., Genco R.J., Wactawski-Wende J. Plasma 25-Hydroxyvitamin D concentrations and periodontal disease in postmenopausal women. J. Periodontol. 2013;84:1243-1256.

    Not in our library10.1902/jop.2012.120445

  109. 109.

    Antonoglou G.N., Knuuttila M., Niemelä O., Raunio T., Karttunen R., Vainio O., Hedberg P., Ylöstalo P., Tervonen T. Low serum level of 1,25(OH)2D is associated with chronic periodontitis. J. Periodontal Res. 2015;50:274-280.

    Not in our library10.1111/jre.12207

  110. 110.

    Meghil M.M., Hutchens L., Raed A., Multani N.A., Rajendran M., Zhu H., Looney S., Elashiry M., Arce R.M., Peacock M.E., et al. The influence of vitamin D supplementation on local and systemic inflammatory markers in periodontitis patients: A pilot study. Oral Dis. 2019;25:1403-1413.

    Not in our library10.1111/odi.13097

  111. 111.

    Taskan M., Gevrek F. PPAR-γ, RXR, VDR, and COX-2 expressions in gingival tissue samples of healthy individuals, periodontitis and peri-implantitis patients MM. Niger. J. Clin. Pract. 2019;22:46-53.

    Not in our library10.4103/njcp.njcp_349_19

  112. 112.

    Hu X., Niu L., Ma C., Huang Y., Yang X., Shi Y., Pan C., Liu J., Wang H., Li Q., et al. Calcitriol decreases live Porphyromonas gingivalis internalized into epithelial cells and monocytes by promoting autophagy. J. Periodontol. 2019.

    Not in our library10.1002/jper.19-0510

  113. 113.

    Han J., Cheng C., Zhu Z., Lin M., Zhang D.X., Wang Z.M., Wang S. Vitamin D reduces the serum levels of inflammatory cytokines in rat models of periodontitis and chronic obstructive pulmonary disease. J. Oral Sci. 2019;61:53-60.

    Not in our library10.2334/josnusd.17-0357

  114. 114.

    Li H., Zhong X., Li W., Wang Q. Effects of 1,25-dihydroxyvitamin on experimental periodontitis and ahr/nf-κb/nlrp3 inflammasome pathway in a mouse model. J. Appl. Oral Sci. 2019;27:1-10.

    Not in our library10.1590/1678-7757-2018-0713

  115. 115.

    Oh C., Kim H.J., Kim H.M. Vitamin D maintains E-cadherin intercellular junctions by downregulating MMP-9 production in human gingival keratinocytes treated by TNF-α. J. Periodontal Implant. Sci. 2019;49:270-286.

    Not in our library10.5051/jpis.2019.49.5.270

  116. 116.

    Wang Q., Zhou X., Zhang P., Zhao P., Nie L., Ji N., Ding Y., Wang Q. 25-Hydroxyvitamin D3 positively regulates periodontal inflammaging via SOCS3/STAT signaling in diabetic mice. Steroids. 2020;156:108570.

    Not in our library10.1016/j.steroids.2019.108570

  117. 117.

    Li H., Li W., Wang Q. 1,25-dihydroxyvitamin D3 suppresses lipopolysaccharide-induced interleukin-6 production through aryl hydrocarbon receptor/nuclear factor-κB signaling in oral epithelial cells. BMC oral health. 2019;19:1-9.

    Not in our library10.1186/s12903-019-0935-x

  118. 118.

    Bi C.S., Wang J., Qu H.L., Li X., Tian B.M., Ge S., Chen F.M. Calcitriol suppresses lipopolysaccharide-induced alveolar bone damage in rats by regulating T helper cell subset polarization. J. Periodontal Res. 2019;54:612-623.

    Not in our library10.1111/jre.12661

  119. 119.

    Hong H., Hong A., Wang C., Huang E., Chiang C. Calcitriol exerts a mineralization-inductive effect comparable to that of vitamin C in cultured human periodontium cells. Am. J. Transl. Res. 2019;11:2304-2316.

    Not in our library

  120. 120.

    Anand A., Singh S., Sonkar A.A., Husain N., Singh K.R., Singh S., Kushwaha J.K. Expression of Vitamin D receptor and Vitamin D status in patients with oral neoplasms and effect of Vitamin D supplementation on quality of life in advanced cancer treatment. Wspolczesna Onkol. 2017;21:145-151.

    Not in our library10.5114/wo.2017.68623

  121. 121.

    Yu X., Zong X., Pan Y. Associations between vitamin D receptor genetic variants and periodontitis: A meta-analysis. Acta Odontol. Scand. 2019;77:484-494.

    Not in our library10.1080/00016357.2019.1597160

  122. 122.

    Wan Q.S., Li L., Yang S.K., Liu Z.L., Song N. Role of Vitamin D receptor gene polymorphisms on the susceptibility to periodontitis: A meta-analysis of a controversial issue. Genet. Test. Mol. Biomark. 2019;23:618-633.

    Not in our library10.1089/gtmb.2019.0021

  123. 123.

    Gao W., Tang H., Wang D., Zhou X., Song Y., Wang Z. Effect of short-term vitamin D supplementation after nonsurgical periodontal treatment: A randomized, double-masked, placebo-controlled clinical trial. J. Periodontal Res. 2020;1-9.

    Not in our library10.1111/jre.12719

  124. 124.

    Patil V., Mali R., Moghe A. Evaluation and comparison of Vitamin D receptors in periodontal ligament tissue of Vitamin D-deficient chronic periodontitis patients before and after supplementation of Vitamin D3. J. Indian Soc. Periodontol. 2019;23:100-105.

    Not in our library10.4103/jisp.jisp_173_18

  125. 125.

    Bashutski J.D., Eber R.M., Kinney J.S., Benavides E., Maitra S., Braun T.M., Giannobile W.V., McCauley L.K. The impact of vitamin D status on periodontal surgery outcomes. J. Dent. Res. 2011;90:1007-1012.

    Not in our library10.1177/0022034511407771

  126. 126.

    Boggess K.A., Espinola J.A., Moss K., Beck J., Offenbacher S., Camargo C.A. Vitamin D status and periodontal disease among pregnant women. J. Periodontol. 2011;82:195-200.

    Not in our library10.1902/jop.2010.100384

  127. 127.

    Sablok A., Batra A., Thariani K., Batra A., Bharti R., Aggarwal A.R., Kabi B.C., Chellani H. Supplementation of Vitamin D in pregnancy and its correlation with feto-maternal outcome. Clin. Endocrinol. (Oxf.). 2015;83:536-541.

    Not in our library10.1111/cen.12751

  128. 128.

    Khan F.R., Ahmad T., Hussain R., Bhutta Z.A. A randomized controlled trial of oral Vitamin D supplementation in pregnancy to improve maternal periodontal health and birth weight. J. Int. Oral Health. 2016;8:657-665.

    Not in our library

  129. 129.

    Khan F., Ahmad T., Hussain R., Bhutta Z. Relationship among Hypovitaminosis D, maternal periodontal disease, and low birth weight. J. Coll. Physicians Surg. Pak. 2018;28:36-39.

    Not in our library10.29271/jcpsp.2018.01.36

  130. 130.

    Sabharwal A., Gomes-Filho I.S., Stellrecht E., Scannapieco F.A. Role of periodontal therapy in management of common complex systemic diseases and conditions: An update. Periodontology 2000. 2018;78:212-226.

    Not in our library10.1111/prd.12226

  131. 131.

    Iheozor-Ejiofor Z., Middleton P., Esposito M., Glenny A.M. Treating periodontal disease for preventing adverse birth outcomes in pregnant women. Cochrane Database Syst. Rev. 2017;2017:CD005297.

    Not in our library10.1002/14651858.cd005297.pub3

  132. 132.

    Albandar J.M., Susin C., Hughes F.J. Manifestations of systemic diseases and conditions that affect the periodontal attachment apparatus: Case definitions and diagnostic considerations. J. Clin. Periodontol. 2018;45:S171-S189.

    Not in our library10.1111/jcpe.12947

  133. 133.

    Wei S.Q., Qi H.P., Luo Z.C., Fraser W.D. Maternal vitamin D status and adverse pregnancy outcomes: A systematic review and meta-analysis. J. Matern. Neonatal Med. 2013;26:889-899.

    Not in our library10.3109/14767058.2013.765849

  134. 134.

    Ziuchkovski J.P., Fields H.W., Johnston W.M., Lindsey D.T. Assessment of perceived orthodontic appliance attractiveness. Am. J. Orthod. Dentofac. Orthop. 2008;133:68-78.

    Not in our library10.1016/j.ajodo.2006.07.025

  135. 135.

    Sarver D.M. Interactions of hard tissues, soft tissues, and growth over time, and their impact on orthodontic diagnosis and treatment planning. Am. J. Orthod. Dentofac. Orthop. 2015;148:380-386.

    Not in our library10.1016/j.ajodo.2015.04.030

  136. 136.

    Kawakami M., Takano-Yamamoto T. Local injection of 1,25-dihydroxyvitamin D3 enhanced bone formation for tooth stabilization after experimental tooth movement in rats. J. Bone Miner. Metab. 2004;22:541-546.

    Not in our library10.1007/s00774-004-0521-3

  137. 137.

    Anderson P.H. Vitamin D activity and metabolism in bone. Curr. Osteoporos. Rep. 2017;15:443-449.

    Not in our library10.1007/s11914-017-0394-8

  138. 138.

    van Driel M., van Leeuwen J.P.T.M. Vitamin D endocrinology of bone mineralization. Mol. Cell. Endocrinol. 2017;453:46-51.

    Not in our library10.1016/j.mce.2017.06.008

  139. 139.

    Meikle M.C. The tissue, cellular, and molecular regulation of orthodontic tooth movement: 100 years after carl sandstedt. Eur. J. Orthod. 2006;28:221-240.

    Not in our library10.1093/ejo/cjl001

  140. 140.

    Davidovitch Z., Finkelson M.D., Steigman S., Shanfeld J.L., Montgomery P.C., Korostoff E. Electric currents, bone remodeling, and orthodontic tooth movement. Am. J. Orthod. Dentofac. Orthop. 1980;77:14-32.

    Not in our library10.1016/0002-9416(80)90221-3

  141. 141.

    Yamasaki K., Shibata Y., Imai S., Tani Y., Shibasaki Y., Fukuhara T. Clinical application of prostaglandin E 1 (PGE 1 ) upon orthodontic tooth movement. Am. J. Orthod. 1984;85:508-518.

    Not in our library10.1016/0002-9416(84)90091-5

  142. 142.

    Stark T.N.I., Sinclair P.M. Effect of pulsed electromagnetic fields on orthodontic tooth movement. Am. J. Orthod. Dentofac. Orthop. 1987;91:91-104.

    Not in our library10.1016/0889-5406(87)90465-3

  143. 143.

    Boyce R.W., Weisbrode S.E. Histogenesis of hyperosteoidosis in 1,25(OH)2D3-treated rats fed high levels of dietary calcium. Bone. 1985;6:105-112.

    Not in our library10.1016/8756-3282(85)90314-x

  144. 144.

    Kale S., Kocadereli I., Atilla P., Aşan E. Comparison of the effects of 1,25 dihydroxycholecalciferol and prostaglandin E2 on orthodontic tooth movement. Am. J. Orthod. Dentofac. Orthop. 2004;125:607-614.

    Not in our library10.1016/j.ajodo.2003.06.002

  145. 145.

    Collins M.K., Sinclair P.M. The local use of vitamin D to increase the rate of orthodontic tooth movement. Am. J. Orthod. Dentofac. Orthop. 1988;94:278-284.

    Not in our library10.1016/0889-5406(88)90052-2

  146. 146.

    Lipworth L., Rossi M., McLaughlin J.K., Negri E., Talamini R., Levi F., Franceschi S., La Vecchia C. Dietary vitamin D and cancers of the oral cavity and esophagus. Ann. Oncol. 2009;20:1576-1581.

    Not in our library10.1093/annonc/mdp036

  147. 147.

    Lehrer S., Montazem A., Ramanathan L., Pessin-Minsley M., Pfail J., Stock R.G., Kogan R. Normal serum bone markers in bisphosphonate-induced osteonecrosis of the jaws. Oral Surgery Oral Med. Oral Pathol. Oral Radiol. Endodontol. 2008;106:389-391.

    Not in our library10.1016/j.tripleo.2008.01.033

  148. 148.

    Bedogni A., Bettini G., Bedogni G., Basso D., Gatti D., Valisena S., Brunello A., Sorio M., Berno T., Giannini S., et al. Is vitamin D deficiency a risk factor for osteonecrosis of the jaw in patients with cancer? A matched case–control study. J. Cranio-Maxillofac. Surg. 2019;47:1203-1208.

    Not in our library10.1016/j.jcms.2019.03.007

  149. 149.

    Heim N., Warwas F.B., Wilms C.T., Reich R.H., Martini M. Vitamin D (25-OHD) deficiency may increase the prevalence of medication-related osteonecrosis of the jaw. J. Cranio-Maxillofac. Surg. 2017;45:2068-2074.

    Not in our library10.1016/j.jcms.2017.09.015

  150. 150.

    Lowe L.C., Guy M., Mansi J.L., Peckitt C., Bliss J., Wilson R.G., Colston K.W. Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population. Eur. J. Cancer. 2005;41:1164-1169.

    Not in our library10.1016/j.ejca.2005.01.017

  151. 151.

    Badros A., Goloubeva O., Evangelos T., Todd M., Maria R.B., Elizabeth S. Prevalence and significance of vitamin D deficiency in multiple myeloma patients. Br. J. Haematol. 2008;142:492-494.

    Not in our library10.1111/j.1365-2141.2008.07214.x

  152. 152.

    Sugimoto T., Matsumoto T., Hosoi T., Miki T., Gorai I., Yoshikawa H., Tanaka Y., Tanaka S., Fukunaga M., Sone T., et al. Three-year denosumab treatment in postmenopausal Japanese women and men with osteoporosis: Results from a 1-year open-label extension of the Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT). Osteoporos. Int. 2014;26:765-774.

    Not in our library10.1007/s00198-014-2964-2

  153. 153.

    Demircan S., Isler S. Changes in serological bone turnover markers in bisphosphonate induced osteonecrosis of the jaws: A case control study. Niger. J. Clin. Pract. 2020;23:154-158.

    Not in our library10.4103/njcp.njcp_374_19

  154. 154.

    Danila M.I., Outman R.C., Rahn E.J., Mudano A.S., Redden D.T., Li P., Allison J.J., Anderson F.A., Wyman A., Greenspan S.L., et al. Evaluation of a multimodal, direct-to-patient educational intervention targeting barriers to osteoporosis care: A randomized clinical trial. J. Bone Miner. Res. 2018;33:763-772.

    Not in our library10.1002/jbmr.3395

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.